10X Genomics Inc (TXG) — Free Cash Flow Generation Index

Latest as of September 2025: 0.98x

10X Genomics Inc (TXG) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of $42.53 Million represents 1% of operating cash flow ($43.21 Million). See how liquid is 10X Genomics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

$42.53 Million
USD

Operating Cash Flow

$43.21 Million
USD

Capital Expenditures

$687.00K
USD

10X Genomics Inc Free Cash Flow Generation Index (2019–2024)

Historical FCF Generation Index trend for 10X Genomics Inc across 2 annual periods. Explore cash flow to debt ratio of 10X Genomics Inc to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for 10X Genomics Inc (2019–2024)

Year-by-year Free Cash Flow Generation Index for 10X Genomics Inc. For the full company profile including market capitalisation, see TXG stock market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 -0.86x $-5.73 Million $6.66 Million $12.39 Million ▼ -265.7%
2019 -0.24x $-8.14 Million $34.63 Million $42.77 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).